HopeStage
Back to all studies
TerminatedNCT00329108

Ziprasidone And Olanzapine's Outcomes In Mania

Medication studyAges 18–65Multiple countriesBipolarity
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Aachen and 18 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 2006
Recruitment status
Terminated
Enrollment listed in the registry
29
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany, Greece, Italy, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00329108
Official title
Show the full official title

A Multicenter, Randomized, Double-Blind, Parallel Group Study, Comparing The Efficacy And Tolerability Of Ziprasidone (Zeldox, Geodon) vs. Olanzapine (Zyprexa) In The Treatment And Maintenance Of Response In Patients With Acute Mania

Recruitment & locations

Terminated

Aachen, Germany · Augsburg, Germany · Freiburg im Breisgau, Germany

17 more locations
  • Athens, Greece
  • S. Arsenio, Italy
  • Bari, Italy
  • Guardiagrele (CH), Italy
  • Lido Di Camaiore (LU), Italy
  • Partinico (Pa), Italy
  • Perugia, Italy
  • Siena, Italy
  • Torino, Italy
  • Trieste, Italy
  • Terrassa, Spain
  • Alava, Spain
  • Granada, Spain
  • Málaga, Spain
  • Ankara, Türkiye
  • Istanbul, Türkiye
  • Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Does this study involve medication?

Yes. The study involves medication, including ziprasidone hydrochloride and olanzapine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies